» Articles » PMID: 32302879

Design and Discovery of Boronic Acid Drugs

Overview
Journal Eur J Med Chem
Specialty Chemistry
Date 2020 Apr 18
PMID 32302879
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Research related to boronic acids, from synthetic development to materials to drug discovery, has skyrocketed in the past 20 years. In terms of drug discovery, the incorporation of boronic acids into medicinal chemistry endeavours has seen a steady increase in recent years. In fact, the Food and Drug Administration (FDA) and Health Canada have thus far approved five boronic acid drugs, three of which were approved in the past four years, and several others are in clinical trials. Boronic acids have several desirable properties that has led to their increased use, including potentially enhancing potency of drugs and/or improving their pharmacokinetics profile. This review explores discovery processes of boronic acid drugs. It begins with a brief scope of boron in natural products and in current drugs, followed by an investigation into the various rationalizations for boronic acid incorporation and the synthetic developments that focused on facilitating their addition into organic compounds. We hope that the knowledge we have assembled in this literature review will encourage medicinal chemists to consider the potential benefits of incorporating boronic acids into their future drug discovery endeavours.

Citing Articles

Synthesis and Evaluation of Boron-Containing Heterocyclic Compounds with Antimicrobial and Anticancer Activities.

Prates J, de Matos Silva S, Medina-Alarcon K, Dos Santos K, Belizario J, Lopes J Molecules. 2025; 30(5).

PMID: 40076340 PMC: 11901438. DOI: 10.3390/molecules30051117.


Photocatalytic [3 + 2]-annulation sodium tetraarylborate: a fundamental approach for synthesizing 1,4,2-diazaborole analogs.

Qin H, Jiang H, Zhao Y, Qurban S, Wang K, Xu P Chem Sci. 2025; 16(6):2837-2842.

PMID: 39811006 PMC: 11727696. DOI: 10.1039/d4sc08085h.


Versatile Stimuli-Responsive Controlled Release of Pinanediol-Caged Boronic Esters for Spatiotemporal and Nitroreductase-Selective Glucose Bioimaging.

Kao C, Chen Y, Liu Y, Wei J, Wang T ACS Sens. 2025; 10(1):470-479.

PMID: 39750141 PMC: 11773560. DOI: 10.1021/acssensors.4c02811.


Activity of Organoboron Compounds against Biofilm-Forming Pathogens.

Konaklieva M, Plotkin B Antibiotics (Basel). 2024; 13(10).

PMID: 39452196 PMC: 11504661. DOI: 10.3390/antibiotics13100929.


Replacement of nitro function by free boronic acid in non-steroidal anti-androgens.

Slechta P, Vitak R, Barta P, Koucka K, Berkova M, Zdarova D RSC Med Chem. 2024; .

PMID: 39345716 PMC: 11428147. DOI: 10.1039/d4md00343h.